{Reference Type}: Journal Article
{Title}: Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer.
{Author}: Wang H;Sun H;Huang J;Zhang Z;Cai G;Wang C;Xiao K;Xiong X;Zhang J;Liu P;Lu X;Feng W;Wang J;
{Journal}: EMBO Mol Med
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 31
{Factor}: 14.26
{DOI}: 10.1038/s44321-024-00108-z
{Abstract}: Small-cell lung cancer (SCLC) is the most aggressive and lethal type of lung cancer, characterized by limited treatment options, early and frequent metastasis. However, the determinants of metastasis in SCLC are poorly defined. Here, we show that estrogen-related receptor gamma (ERRγ) is overexpressed in metastatic SCLC tumors, and is positively associated with SCLC progression. ERRγ functions as an essential activator of extracellular matrix (ECM) remodeling and cell adhesion, two critical steps in metastasis, by directly regulating the expression of major genes involved in these processes. Genetic and pharmacological inhibition of ERRγ markedly reduces collagen production, cell-matrix adhesion, microfilament production, and eventually blocks SCLC cell invasion and tumor metastasis. Notably, ERRγ antagonists significantly suppressed tumor growth and metastasis and restored SCLC vulnerability to chemotherapy in multiple cell-derived and patient-derived xenograft models. Taken together, these findings establish ERRγ as an attractive target for metastatic SCLC and provide a potential pharmacological strategy for treating this lethal disease.